Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LOXO | CORT | CNTA | ||
| Company | Loxo Oncology CS | Corcept Therapeutics | Centessa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 234.80 | 82.91 | 39.75 | ||
| High | 234.80 | 84.79 | 39.80 | ||
| Low | 234.80 | 82.40 | 39.64 | ||
| Latest | 234.80 | 82.91 | 39.72 | ||
| Change | +0.14 | -0.34 | -0.05 | ||
| % Change | +0.06% | -0.41% | -0.13% | ||
| Volume | 800 | 719,100 | 1,322,700 | ||
| 20-Day Average Volume | 642,620 | 999,915 | 1,175,875 | ||
| Previous Close | 234.66 | 83.25 | 39.77 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 234.28 | 68.52 | 39.75 | ||
| 20-Day Raw Stochastic | 92.26% | 93.77% | 38.55% | ||
| 20-Day Relative Strength | 75.87 | 83.13 | 66.08 | ||
| Weighted Alpha | +47.60 | +136.85 | +118.65 | ||
| Today's Opinion | 100% Buy | 72% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Buy | 8% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 02/08/19 | +14.17% since 06/05/26 | +0.25% since 06/05/26 | ||
| Low | 234.43 on 02/11/19 | 72.62 on 06/08/26 | 39.58 on 06/09/26 | ||
| High | 234.93 on 02/13/19 | 84.79 on 06/12/26 | 39.83 on 06/09/26 | ||
| 1-Month | |||||
| %Chg | +0.48% since 01/15/19 | +62.06% since 05/12/26 | +0.28% since 05/12/26 | ||
| Low | 233.14 on 01/16/19 | 53.30 on 05/13/26 | 39.53 on 05/13/26 | ||
| High | 234.93 on 02/13/19 | 84.79 on 06/12/26 | 39.97 on 06/02/26 | ||
| 3-Month | |||||
| %Chg | +54.95% since 11/15/18 | +155.97% since 03/12/26 | +45.92% since 03/12/26 | ||
| Low | 125.00 on 12/24/18 | 31.81 on 03/13/26 | 25.17 on 03/24/26 | ||
| High | 234.93 on 02/13/19 | 84.79 on 06/12/26 | 40.26 on 03/31/26 | ||
| 6-Month | |||||
| %Chg | +49.33% since 08/15/18 | -5.77% since 12/12/25 | +49.83% since 12/12/25 | ||
| Low | 125.00 on 12/24/18 | 28.66 on 02/19/26 | 21.50 on 01/20/26 | ||
| High | 234.93 on 02/13/19 | 89.00 on 12/15/25 | 40.26 on 03/31/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,182,943 | 8,900,554 | 5,927,336 | ||
| Shares Outstanding, K | 30,615 | 107,352 | 149,228 | ||
| Annual Sales | 21,300,000 | 761,410,000 | 15,000,000 | ||
| Annual Net Income | -148,880,000 | 99,650,000 | -197,530,000 | ||
| Last Quarter Sales | 42,470,000 | 164,900,000 | 0 | ||
| Last Quarter Net Income | -27,060,000 | -31,760,000 | -79,240,000 | ||
| 60-Month Beta | 2.51 | 0.50 | 1.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.89 on 11/08/18 | -0.30 on 04/30/26 | -0.52 on 05/05/26 | ||
| Earnings Date | 03/07/19 | 07/30/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 237.86 | 0.00 | ||